Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04406740 · ClinicalTrials.gov registry record
Clinical Evaluation of a Novel Neuromuscular Blockade Monitoring System
A clinical trial, sponsored by University of Minnesota.
- Terminated
- Registry status
- 9
- Enrollment target
NCT04406740: Clinical Trial study, sponsored by University of Minnesota.
NCT04406740 is a clinical trial that was terminated before completion, run by University of Minnesota. The registered enrollment target is 9 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT04406740 was terminated before completion, sponsored by University of Minnesota.
- TERMINATED
- Registry status
- 9 participants
- Enrollment target
Study Summary
This study is designed to formally evaluate the performance of the QTOF, as compared with the newest commercially available NMB monitoring equipment, EMG (the TwitchView).
Primary Outcome
The train-of-four ratio (unitless measure) is calculated by comparing the magnitude of the fourth evoked response or twitch (T4) to that of the first response (T1).
Interventions
- DEVICE TwitchView EMG Unit
- DEVICE Novel QTOF Device
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 9 participants |
| Start Date | 2018-06-18 |
| Est. Completion | 2021-06-01 |
Why NCT04406740 stopped before completion
NCT04406740 is an observational study that tracks outcomes without assigning an intervention. The registry caps enrollment at 9 participants, a relatively small participant target.
The record links to 0 conditions, and to 2 interventions - of which TwitchView EMG Unit is the first listed.
NCT04406740 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT04406740 about?
NCT04406740 is a clinical study titled "Clinical Evaluation of a Novel Neuromuscular Blockade Monitoring System". This study is designed to formally evaluate the performance of the QTOF, as compared with the newest commercially available NMB monitoring equipment, EMG (the TwitchView).
What is the current status of trial NCT04406740?
This trial is currently terminated. The enrollment target is 9 participants. The study started on 2018-06-18. Estimated completion is 2021-06-01.
What interventions are being tested in trial NCT04406740?
The interventions under investigation include: TwitchView EMG Unit (DEVICE), Novel QTOF Device (DEVICE).
Who is sponsoring clinical trial NCT04406740?
This trial is sponsored by University of Minnesota, which has 966 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI